Status:
COMPLETED
Evaluation of the Dermal Cooling System for Treatment of Common Skin Conditions
Lead Sponsor:
R2 Dermatology
Conditions:
Skin Lesion
Eligibility:
All Genders
18+ years
Phase:
NA
Brief Summary
The purpose of this study is to evaluate whether the Dermal Cooling System can be used to elicit an improvement in the cosmetic appearance or physical symptoms of common skin conditions.
Detailed Description
This is a prospective, non-randomized, open-label study to evaluate the effectiveness of the Dermal Cooling system to determine if cosmetic benefits or physical symptoms are achieved in common skin co...
Eligibility Criteria
Inclusion
- Male or female subjects \> 18 years of age.
- Subject has a skin condition amenable to cryosurgical treatment including, for example, psoriasis, atopic dermatitis, acne, rosacea, and melasma.
- Subject is willing to have skin exposed to cooling with the Dermal Cooling System.
- Subject is willing to have digital photographs taken of the treatment area and agrees to use of photographs for presentation, educational, or marketing purposes.
- Subject is willing to cover treated area or have very limited sun exposure and use an approved sunscreen of SPF 50 or higher on the treated area for the duration of the study, including the follow-up period, if requested.
- Subject has read and signed a written informed consent form.
- Subject is willing to comply with adjuvant topical regimen, as applicable.
- Subject agrees not to undergo any other procedure(s) in the treatment area during the study.
Exclusion
- Dermatological conditions (e.g. vitiligo, open wounds, infection, pre-cancerous or malignant lesions) in the location of the treatment sites that would, in the professional opinion of the investigator, potentially pose an increased risk to the subject
- Use of Accutane within the previous 6 months
- History of melanoma
- Subject is pregnant or intending to become pregnant during the study period
- Subject is lactating or has been lactating in the past 6 months
- Known history of illness or adverse reaction to cold insult (e.g., cryoglobulinemia, cold urticaria, paroxysmal cold hemoglobinuria, Reynaud's disease.
- History of abnormal wound healing or abnormal scarring
- Inability or unwillingness to comply with the study requirements.
- Current enrollment in a clinical study of any other unapproved investigational drug or device.
- Any other condition or laboratory value that would, in the professional opinion of the investigator, potentially affect response or participation in this clinical study, or would pose an unacceptable risk to the subject.
Key Trial Info
Start Date :
December 10 2021
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
November 1 2023
Estimated Enrollment :
88 Patients enrolled
Trial Details
Trial ID
NCT05270512
Start Date
December 10 2021
End Date
November 1 2023
Last Update
November 22 2024
Active Locations (4)
Enter a location and click search to find clinical trials sorted by distance.
1
West Coast Research
Dublin, California, United States, 94568
2
Oak Dermatology
Naperville, Illinois, United States, 60563
3
Skin Search of Rochester, Inc.
Rochester, New York, United States, 14623
4
Dermatology, Laser and Vein Specialists of the Carolinas
Charlotte, North Carolina, United States, 28207